bioRxivCell BiologyPreprint
A biomathematical approaches models to identify human platelet activation signature in response to various agonists
Fabrice CognasseiD, Kim Anh NguyeniD, Marco HeestermansiD, Charles‐Antoine Arthaud, Marie‐Ange Eyraud, Amélie Prier, Simon de Bernard, Julien NourikyaniD, Anne‐Claire DucheziD, Stéphane AvriliD, Olivier GarraudiD, Hind Hamzeh‐CognasseiD
Abstract
BackgroundPlatelets are crucial mediators at the crossroads of hemostasis, immunity, and inflammation, adapting their responses to diverse stimuli. Despite their recognized role, the precise pathways and markers associated with platelet activation remain poorly understood. This study aimed to unravel these mechanisms by evaluating platelet responses to various agonists, employing biomathematical models to map activation patterns and identify key biomarkers. MethodsUsing samples from ten healthy donors, platelets were exposed to seven stimulation conditions: unstimulated, PAR-1 agonist TRAP, PAR-4 agonist AYPGKF, ADP, collagen, sCD40L, and fibrinogen. A comprehensive analysis of 47 biological markers--covering membrane activation, soluble mediators, and signaling pathways--was conducted. Statistical and machine learning models, including hierarchical clustering and random forests, were applied to classify and interpret platelet activation signatures. ResultsDistinct activation profiles were observed for each agonist. A streamlined panel of six markers--AKT, CD40 ligand, CD62P (mean fluorescence intensity and percentage), PKC, RANTES, and TSLP--achieved 86.8% accuracy in identifying the activating stimulus. The study highlighted significant variations, influenced by both the stimulus and donor-specific factors. Machine learning approaches further refined classification, achieving a multiclass accuracy of 87.9%. Hierarchical clustering demonstrated clear distinctions, particularly between PAR-1/PAR-4 responses and other agonists. ConclusionThis innovative research redefines platelets as dynamic "biological sensors" capable of decoding complex danger signals. By integrating biomathematical modeling and artificial intelligence, it identifies a precise biomarker panel with transformative potential for diagnostics and therapies in inflammation and immune disorders. This work positions platelets not just as key players in hemostasis but as programmable agents for precision medicine, heralding a new era in adaptive, AI-driven healthcare solutions. Author SummaryPlatelets are often seen as simple players in blood clotting, but they do much more. They sit at the crossroads of hemostasis (stopping bleeding), innate immunity (our bodys first defense), and inflammation. They even influence adaptive immunity and play key roles in maintaining healthy blood vessels and contributing to disease. What makes platelets fascinating is their ability to respond quickly to their environment. They carry various receptors and release substances like growth factors, immune signals, clotting factors, RNA, and tiny vesicles. This helps them react to threats and communicate with other cells. But the big question is: can platelets tailor their response based on specific stimuli? In my research, I set out to answer this. Using mathematical models and analytical techniques, I studied how platelets react to different triggers, especially those linked to immune and clotting responses. My goal was to identify specific molecular "signatures" that define how platelets respond. I found that platelets can distinguish between danger signals and adjust their secretory responses. Normally, this helps manage threats efficiently. However, when this response exceeds whats needed, it can contribute to diseases like cardiovascular disorders, severe infections, autoimmune conditions, and cancer. Understanding these pathways opens new doors for treatment. Since platelet activity can be influenced by drugs, we could shift their role from harmful to beneficial in many diseases. This could revolutionize how we approach conditions driven by inflammation and immune dysregulation. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/636809v1_ufig1.gif" ALT="Figure 1"> View larger version (30K): org.highwire.dtl.DTLVardef@9d9b5forg.highwire.dtl.DTLVardef@1438071org.highwire.dtl.DTLVardef@a59b29org.highwire.dtl.DTLVardef@6dd66b_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: proteomics
- research focus: cell type annotation
- approach: machine learning (classical)
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multi-parameter phenotyping of platelets and characterisation of the effects of agonists using machine learning
A. Vadgama, J. Boot, … T. D. Warner·bioRxiv·Dec 8, 2023
- Classification of platelet aggregates by agonist type
Y. Zhou, A. Yasumoto, … K. Goda·bioRxiv·Oct 20, 2019
- Complement factor C4a does not activate protease activated receptor 1 (PAR1) or PAR4 on human platelets.
X. Han, M. de la Fuente, M. T. Nieman·bioRxiv·Jun 1, 2020
- High Mobility Group Box 1 enhances ADP-mediated platelet activation by increasing platelet surface P2Y12 localization
D. Nolfi-Donegan, G. Annarapu, … S. Shiva·bioRxiv·Mar 24, 2021
- Platelet and releasate lipidomics identify novel platelet activating mechanisms and ether-linked lysophosphatidylcholine and phosphatidylethanolamine 38:7 as predictors for platelet reactivity
Kang‐Yu Peng·bioRxiv·Oct 9, 2025
- Droplet microfluidics reports digital and tuneable single-platelet ADP secretion describing primed, active and hyper-active states
Max Seidy Saito, Theo Hornsey, … Jonathan J. West·bioRxiv·Jul 28, 2026